0      0

AONN+ Midyear 2022

SAT03 - Genomic Profiling in Early Stage Breast Cancer| Presentation by Agendia

May 14, 2022 9:45am ‐ May 14, 2022 10:45am


This presentation will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, in patients with breast cancer. Dr. William Audeh, Chief Medical Officer at Agendia will discuss how real-world evidence and published data can be used to improve outcomes and patient management based on MammaPrint and BluePrint results. Attendees will participate in an interactive Q&A at the end of the presentation.


You must be logged in and own this session in order to post comments.